Keyphrases
Breast Cancer
100%
Triple-negative Breast Cancer
100%
ERK2
100%
Cell Proliferation
50%
Tumor Formation
50%
Xenograft Tumor
50%
Colony Formation
50%
Therapeutic Target
25%
Tumor Growth
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
25%
Signaling Pathway
25%
Overexpression
25%
Estrogen Receptor
25%
Progesterone Receptor
25%
Tumor Progression
25%
Tumor Metastasis
25%
Epidermal Growth Factor Receptor
25%
Knockdown
25%
Oncogenic Properties
25%
High Mortality Rate
25%
Triple-negative Breast Cancer Cells
25%
MDA-MB-231 Cancer Cells
25%
MDA-MB-468
25%
MDA-MB-468 Cell Line
25%
Molecular Therapeutic Targets
25%
MDA-MB-231 Cell Line
25%
Breast Cancer Tissues
25%
Human Triple Negative Breast Cancer
25%
Biochemistry, Genetics and Molecular Biology
MDA-MB-468
100%
Cell Proliferation
100%
Colony Formation
100%
Carcinogenesis
100%
Tumor Progression
100%
Signal Transduction
50%
Cancer Cell
50%
Mortality Rate
50%
Estrogen Receptor
50%
Epidermal Growth Factor Receptor
50%
Progesterone Receptor
50%
Immunology and Microbiology
Xenograft
100%
Cell Proliferation
100%
Colony Formation
100%
Mortality Rate
50%
Breast Cancer Cell Line
50%
Cancer Tissue
50%
MDA-MB-231 Cell Line
50%
Gamma Urogastrone
50%
MDA-MB-468 Cell Line
50%
Signal Transduction
50%
Medicine and Dentistry
Breast Cancer
100%
Triple Negative Breast Cancer
100%
Tumor Progression
33%
Xenograft
33%
Carcinogenesis
33%
Cell Proliferation
33%
Colony Formation
33%
Malignant Neoplasm
16%
Metastatic Carcinoma
16%
Mortality Rate
16%
Gamma Urogastrone
16%
Epidermal Growth Factor Receptor 2
16%
Cancer Tissue
16%
Breast Cancer Cell Line
16%
MDA-MB-231 Cell Line
16%
MDA-MB-468 Cell Line
16%
Estrogen Receptor
16%
Signal Transduction
16%
Progesterone Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Triple Negative Breast Cancer
100%
Tumor Growth
33%
Carcinogenesis
33%
Estrogen Receptor
16%
Malignant Neoplasm
16%
Metastasis
16%
Mortality Rate
16%
Gamma Urogastrone
16%
Epidermal Growth Factor Receptor 2
16%
Progesterone Receptor
16%